2024
DOI: 10.1007/s12328-024-02087-7
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of fruquintinib’s efficacy and safety in refractory metastatic colorectal cancer: a systematic review and meta-analysis of phase II and III randomized controlled trials

Eric Ricardo Yonatan,
Rivaldi Ruby,
Alver Prasetya
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 25 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?